These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37485888)

  • 1. Experience of treatment of chronic migraine with botulinum toxin type A among aesthetic medicine professionals in Poland.
    Boczarska-Jedynak M
    Neurol Neurochir Pol; 2023; 57(4):363-370. PubMed ID: 37485888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injection technique of the upper face with onabotulinumtoxinA in chronic migraine.
    Boczarska-Jedynak M; Blumenfeld AM
    Headache; 2023; 63(7):849-860. PubMed ID: 37366143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onabotulinum toxin A (Botox) for chronic migraine treatment: an Italian experience.
    Grazzi L; Usai S
    Neurol Sci; 2015 May; 36 Suppl 1():33-5. PubMed ID: 26017508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxins for the prevention of migraine in adults.
    Herd CP; Tomlinson CL; Rick C; Scotton WJ; Edwards J; Ives N; Clarke CE; Sinclair A
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD011616. PubMed ID: 29939406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm.
    Martinelli D; Arceri S; De Icco R; Allena M; Guaschino E; Ghiotto N; Bitetto V; Castellazzi G; Cosentino G; Sances G; Tassorelli C
    Cephalalgia; 2022 Feb; 42(2):170-175. PubMed ID: 34404257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of type a botulinum toxin injections and infrared polarized light on treating chronic migraine.
    Song JH; Zhang GB; Ding XD; Huang L; Hong Y; Chen HX
    Eur Rev Med Pharmacol Sci; 2015; 19(11):1976-82. PubMed ID: 26125257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanistic, utilization, and cost outcomes associated with the use of botulinum toxin for treatment of refractory migraine headaches in a managed care organization.
    Mitchell MP; Schaecher K; Cannon HE; Speckman M
    J Manag Care Pharm; 2008 Jun; 14(5):442-50. PubMed ID: 18597573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Italian consensus report on the aesthetic use of onabotulinum toxin A.
    Bertossi D; Cavallini M; Cirillo P; Piero Fundarò S; Quartucci S; Sciuto C; Tonini D; Trocchi G; Signorini M
    J Cosmet Dermatol; 2018 Oct; 17(5):719-730. PubMed ID: 30091253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group.
    Silberstein S; Mathew N; Saper J; Jenkins S
    Headache; 2000 Jun; 40(6):445-50. PubMed ID: 10849039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A for the treatment of migraine.
    Aurora S
    Expert Opin Pharmacother; 2006 Jun; 7(8):1085-95. PubMed ID: 16722818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of two different botulinum toxin type A dilutions in chronic migraineurs.
    Tereshko Y; Lettieri C; Belgrado E; Pez S; Gigli GL; Valente M
    Toxicon; 2023 May; 227():107096. PubMed ID: 36965713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine--a global, evidence-based botulinum toxin consensus education initiative: part II: incorporating botulinum toxin into aesthetic clinical practice.
    Carruthers J; Fournier N; Kerscher M; Ruiz-Avila J; Trindade de Almeida AR; Kaeuper G
    Dermatol Surg; 2013 Mar; 39(3 Pt 2):510-25. PubMed ID: 23458295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum Toxin versus Placebo: A Meta-Analysis of Prophylactic Treatment for Migraine.
    Bruloy E; Sinna R; Grolleau JL; Bout-Roumazeilles A; Berard E; Chaput B
    Plast Reconstr Surg; 2019 Jan; 143(1):239-250. PubMed ID: 30589800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Botulinum toxin injections for chronic migraine in adolescents - an early therapeutic option in the transition from neuropaediatrics to neurology].
    Bernhard MK; Bertsche A; Syrbe S; Weise S; Merkenschlager A
    Fortschr Neurol Psychiatr; 2014 Jan; 82(1):39-42. PubMed ID: 24446117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin: A review of the mode of action in migraine.
    Do TP; Hvedstrup J; Schytz HW
    Acta Neurol Scand; 2018 May; 137(5):442-451. PubMed ID: 29405250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OnabotulinumtoxinA injection in the treatment of chronic migraine.
    Wang YF
    Prog Brain Res; 2020; 255():171-206. PubMed ID: 33008506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine.
    Herd CP; Tomlinson CL; Rick C; Scotton WJ; Edwards J; Ives NJ; Clarke CE; Sinclair AJ
    BMJ Open; 2019 Jul; 9(7):e027953. PubMed ID: 31315864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of onabotulinum toxin A (Botox(®)) in the treatment of chronic migraine at the Parma Headache Centre: a prospective observational study.
    Russo M; Manzoni GC; Taga A; Genovese A; Veronesi L; Pasquarella C; Sansebastiano GE; Torelli P
    Neurol Sci; 2016 Jul; 37(7):1127-31. PubMed ID: 27048312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A: a new option for treatment of chronic migraine with medication overuse.
    Grazzi L; Usai S
    Neurol Sci; 2014 May; 35 Suppl 1():37-9. PubMed ID: 24867833
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.